ESC Premium Access

Poster Session 6 - Lipids

Event: ESC CONGRESS 2019
Topic: European Society of Cardiology
Session type: Poster Session
Date: 3 September 2019

Congress Session

14 presentations in this session

Reduction in high-sensitivity C-reactive protein by pitavastatin was associated with improved outcomes in Japanese patients with stable coronary artery disease: results from REAL-CAD study

Speaker: Doctor H. Iwata (Tokyo, JP)
Thumbnail

The association of Lp(a) levels and cardiovascular disease in adult patients with familial hypercholesterolemia: analysis from the HELLAS-FH registry

Speaker: Professor E. Liberopoulos (Ioannina, GR)
Thumbnail

Oxidized phospholipids on apolipoprotein B-100 among black US adults with and without PCSK9 loss-of-function variants

Speaker: Doctor M. Mefford (Birmingham, US)
Thumbnail

HDL-C and all-cause mortality in a high-risk population: impact of LDL-C

Speaker: Doctor D. Dhindsa (Atlanta, US)
Thumbnail

Children with familial hypercholesterolemia: lipid profile, treatment and evaluation of different formulas for calculating low-density lipoprotein cholesterol: an analysis from the HELLAS-FH registry

Speaker: Professor E. Liberopoulos (Ioannina, GR)
Thumbnail

A possible paradoxical association between LDL-cholesterol in myocardial infarction patients and relation to major adverse outcomes - a 10-year nationwide cohort study

Speaker: Ms J. Schubert (Uppsala, SE)
Thumbnail

Effect of evolocumab on lipoprotein(a) levels: results across 15 studies

Speaker: Professor P. Toth (Baltimore, US)
Thumbnail

Are we being able to meet current guidelines LDL-cholesterol goals in very high risk patients? How many of them could benefit of PSCK9 inhibition by the FOURIER/ODYSSEY and NICE criteria?

Speaker: Doctor T. El Andere (Sao Paulo, BR)
Thumbnail

Clinical and demographic predictors of attenuated LDL-C response to PCSK9 inhibition with bococizumab: Insights from the SPIRE trials.

Speaker: Doctor H. Siddiqi (Boston, US)
Thumbnail

Montreal score and coronary artery calcification in the prediction of cardiovascular event in patients with familial hypercholesterolemia

Speaker: Associate Professor R. Santos (Sao Paulo, BR)
Thumbnail

14 speakers from this session

Doctor Hiroshi Iwata

Juntendo University School of Medicine, Tokyo (Japan)
0 follower

Professor Evangelos Liberopoulos

University of Ioannina Medical School, Ioannina (Greece)
1 presentation
0 follower

Doctor Matthew Mefford

University of Alabama Birmingham, Birmingham (United States of America)
0 follower

Doctor Devinder Dhindsa

Emory University School of Medicine, Atlanta (United States of America)
0 follower

Professor Evangelos Liberopoulos

University of Ioannina Medical School, Ioannina (Greece)
1 presentation
0 follower

Ms Jessica Schubert

Uppsala University, Uppsala (Sweden)
0 follower

Professor Peter Toth

CGH Medical Center and The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore (United States of America)
2 presentations
0 follower

Doctor Tamer El Andere

Institute Dante Pazzanese of Cardiology, Sao Paulo (Brazil)
0 follower

Doctor Hasan Siddiqi

Brigham and Women's Hospital, Boston (United States of America)
1 presentation
0 follower

Associate Professor Raul Santos

Heart Institute of the University of Sao Paulo (InCor), Sao Paulo (Brazil)
4 presentations
0 follower

Professor Maciej Banach

Medical University of Lodz, Lodz (Poland)
4 presentations
0 follower

Doctor Antonette Karrthik

Cleveland Clinic Foundation, Cleveland (United States of America)
0 follower

Doctor Istvan Reiber

Szent Gyorgy University Teaching Hospital, Szekesfehervar (Hungary)
0 follower

Doctor Tatjana Kuznetsova

Petrozavodsk state university, Petrozavodsk (Russian Federation)
0 follower

This platform is supported by

logo Novo Nordisk